Updated recommendations, panel sessions among highlights at 21st annual WCIRDC meeting
Click Here to Manage Email Alerts
Key takeaways:
- The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease meeting will kick off Thursday morning in Los Angeles.
- The meeting includes four panel discussions on various cardiometabolic topics.
Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) will kick off Thursday morning and continue through Saturday. This year’s meeting will take place in-person at Hilton Universal City in Los Angeles.
“What’s unique in our meeting is it’s the only meeting of its size that covers everything, from basic science to translational science to clinical science, and connecting all the dots,” Yehuda Handelsman, MD, FACP, FNLA, FASCP, FAHA, MACE, chair of WCIRDC and medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, told Healio. “We have several sessions that are looking at basic science and clinical science. That’s an important aspect of the meeting.”
WCIRDC will feature 22 sessions examining a wide range of topics in cardiology, endocrinology, nephrology and primary care. Among the sessions as this year’s meeting will be an update to the Multispecialty Practice Recommendations for the Management of Diabetes, Cardiorenal, and Metabolic Diseases (DCRM), which will be presented Thursday at 3:40 p.m. PST. The recommendations were first presented during the 2021 WCIRDC meeting and included 20 slides that were designed to give clinicians easy-to-follow recommendations for treating common cardiometabolic and renal conditions. Handelsman said updates will be presented at this year’s meeting with a focus on making the recommendations more applicable to health care providers around the world.
“When we developed the DCRM, it was still during COVID, so we couldn’t bring on any [experts] internationally, it was primarily the U.S.,” Handelsman said. “This time, we wanted to see if we can have a global transformation in what we do. We now have 52 experts from the U.S., Canada and all over Europe, they’re again endocrinologists, nephrologists, primary care physicians and cardiologists. We are going topic by topic, updating the topics as needed and also making it relevant to different places across the globe.”
Other featured sessions at this year’s meeting include:
- Several panel sessions will take place throughout the conference. Handelsman said panel sessions are designed to promote active discussion among the panelists and audience. Unlike the traditional three to four lectures per session ending with a short question and answer session, the panel sessions will have shorter lecture presentations followed by discussions. Handelsman said the format guides the audience in how to use the presented data and its implementation to clinical practice. The first panel session will be at 11:15 a.m. PST Thursday and will focus on lipidology. Three more panel sessions will take place on Saturday. At 8:20 a.m. PST, a group of four experts will discuss cardiomyopathy and heart failure, at 1:35 p.m. PST, a panel will talk about contemporary approaches for treating obesity, and at 4 p.m. PST, the final panel session will focus on atherosclerotic CVD imaging.
- Concurrent meet the experts sessions will take place Thursday at 12:15 p.m. PST. The sessions will include Ralph A. DeFronzo, MD, speaking about insulin resistance and intensive management of diabetes; Vivian A. Fonseca, MD, discussing DCRM risk prediction; Jennifer B. Green, MD, speaking about emerging strategies for chronic kidney disease; and Handelsman discussing technology in diabetes and cardiorenal management.
- At 11 a.m. PST Saturday, the Gerald Reaven Distinguished Leader in Insulin Resistance Award will be presented to Paul Zimmet, MD, PhD, professor of diabetes at Monash University in Australia. Zimmet will discuss a historical and epidemiological perspective of insulin resistance and its outcomes in type 2 diabetes during his talk.
This year’s meeting also features an exhibit hall, poster session and oral abstract presentations. Abstracts that are presented at the meeting will also be published in the journal Metabolism.
WCIRDC is an in-person meeting only. Attendees have the option to purchase 90 days of on-demand recordings with access to sessions videos, abstracts and more.
Healio is an official media partner of WCIRDC. The Healio team will provide coverage from WCIRDC, with reports on the presentations, researcher perspectives and more. For more information on the WCIRDC agenda and registration, visit www.wcir.org.
Collapse
Healio Interviews
Click Here to Manage Email Alerts